Jack Anders

Chief Financial OfficeratRevolution Medicines· In proxies 2021–2025

Pay in FY2025Revolution Medicines stock +82.1% the same year

Jack Anders was paid $3.6M in FY2025 (Dec). Revolution Medicines stock rose 82.1% that year.

Pay$100 in the stock at the end of FY20 → $132

Pay is from the Summary Compensation Table of each Revolution Medicines proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

RVMD
Revolution MedicinesPublic company · 5 yr
- Chief Financial Officer2021 – Present · 5 yrStock in role +343%

Roles come from the proxy statements of each company.

Activity

Pay
Revolution Medicines CFO pay rose 56% to $3.0M. The stock rose 20% in FY2023 (Dec).
DEF 14AApr 25, 2024
Pay
Revolution Medicines CFO pay rose 29% to $1.9M. The stock fell 5% in FY2022 (Dec).
DEF 14AApr 25, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?